Clene Inc. Navigates Turbulence in Biopharmaceutical Sector with Innovative Neurotherapeutics
Clene Inc., a clinical-stage biopharmaceutical company, has navigated a tumultuous journey in the development of innovative therapeutics for neurodegenerative diseases, marked by significant stock fluctuations and regulatory challenges.
3 minutes to read